Odivissa Health Research Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 31-12-2024
- Paid Up Capital ₹ 3.77 Cr
as on 31-12-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.39 Cr
as on 31-12-2024
- Revenue 26.56%
(FY 2022)
- Profit 192.31%
(FY 2022)
- Ebitda 32.78%
(FY 2022)
- Net Worth 9.84%
(FY 2022)
- Total Assets 0.14%
(FY 2022)
About Odivissa Health Research
The Corporate was formerly known as Odivissa Health Research Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 3.77 Cr.
The company currently has active open charges totaling ₹3.39 Cr.
Shovan Rath and Doctorbhabani Pati serve as directors at the Company.
- CIN/LLPIN
U85110OR2015PTC018655
- Company No.
018655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Odivissa Health Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shovan Rath  | Director | 02-Feb-2015 | Current |
| Doctorbhabani Pati | Director | 02-Feb-2015 | Current |
Financial Performance of Odivissa Health Research.
Odivissa Health Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.56% increase. The company also saw a substantial improvement in profitability, with a 192.31% increase in profit. The company's net worth moved up by a moderate rise of 9.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Odivissa Health Research?
In 2022, Odivissa Health Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Aug 2021 | ₹3.40 M | Open |
Others Creation Date: 03 Sep 2020 | ₹0.75 M | Open |
Others Creation Date: 29 Jul 2020 | ₹2.85 M | Open |
How Many Employees Work at Odivissa Health Research?
Odivissa Health Research has a workforce of 50 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Odivissa Health Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Odivissa Health Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
